Skip to Content

DV250 (Divalproex Sodium Delayed-Release 250 mg)

Pill with imprint DV250 is Peach, Elliptical / Oval and has been identified as Divalproex Sodium Delayed-Release 250 mg. It is supplied by Genpharm Inc..

Divalproex sodium is used in the treatment of bipolar disorder; mania; epilepsy; migraine prevention and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for DV250

Divalproex sodium delayed-release 250 mg DV250

Divalproex Sodium Delayed-Release

Imprint
DV250
Strength
250 mg
Color
Peach
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Fatty acid derivative anticonvulsants
Pregnancy Category
D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder, X - Not for use in pregnancy - When treating migraine
CSA Schedule
Not a controlled drug
Labeler / Supplier
Genpharm Inc.
National Drug Code (NDC)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.